How to Value a CT Imaging Center in 2026

CT centers are the unloved cousin of MRI in imaging M&A. Multiples look similar on paper — 5-8x EBITDA for independent outpatient CT — but the underlying economics are meaningfully different, and sellers who don't understand those differences end up underselling their business or pricing themselves out of the market entirely.

I've sat across the table from CT center owners who genuinely believed their facility should trade at the same multiple as a neighboring MRI center, and I've seen others who thought the opposite — that CT was a commodity and they should take the first offer. Both views are wrong. Let me walk through how CT centers actually get valued in 2026.

The Multiples: Where CT Centers Trade

Standalone CT centers trade between 5x and 8x EBITDA, with most transactions clustering around 5.5-7x. The 8x+ outliers are centers with specialty cardiac CT programs, lung cancer screening volume, or strong hospital contracts that provide volume guarantees.

On revenue, CT centers are lower-priced-per-study than MRI (a CT chest without contrast reimburses around $150-170 on Medicare vs. $225+ for spine MRI), but they do more volume. A busy single-scanner CT center can easily run 35-50 studies a day, versus 18-25 for a comparable MRI. The result is that a well-run CT center doing $2.8M in revenue and $750K EBITDA trades for roughly $4.2-5.2M in a competitive process.

The strategic buyer pool is the same as MRI — RadNet, Akumin, SimonMed, regional hospital systems, and increasingly cardiology groups looking to internalize cardiac CT. What's different is that CT is more often acquired as part of a multi-modality bundle. Buyers rarely get excited about a standalone single-scanner CT center the way they do about a standalone MRI.

Volume Economics: Why CT Is a Different Math Problem

CT has much higher throughput than MRI. A typical non-contrast CT takes 5-10 minutes in the scanner; a contrast study with oral prep might take 30-45 minutes total but only a fraction of that is on the table. A single-scanner CT site can realistically handle 40+ studies in a 10-hour day.

That throughput advantage cuts both ways. On the upside, fixed-cost leverage is extraordinary — once you clear roughly 18-22 studies a day, every additional scan drops 70-75% contribution margin to EBITDA. On the downside, subscale CT centers are brutal. A center doing 12 studies a day is almost certainly losing money after fully-loaded overhead, and buyers will price that at asset value minus a shutdown discount.

My benchmarks for CT:

• Under 15 studies/day: Subscale. Valuation floor is used equipment value, maybe $200-400K.
• 15-25 studies/day: Marginal. You'll get offers, but multiples cap around 5.0-5.5x.
• 26-40 studies/day: Healthy. This is where strategics engage seriously at 6-7x.
• 40+ studies/day: Strong asset. 7-8x, especially with specialty service lines.

Slice Count and Equipment Economics

Where MRI sellers obsess over field strength, CT sellers should be thinking about slice count and detector rows. The market has effectively split into tiers:

16-slice systems are considered end-of-life for most outpatient applications. They can't do cardiac CT, they're slow for CTA, and manufacturers are phasing out service support. If you're selling a center with a 16-slice scanner as the primary asset, buyers will assume replacement is imminent and deduct $500-800K from their offer.

64-slice systems are the current workhorse. They handle essentially all routine outpatient indications, do basic cardiac calcium scoring, and have plenty of remaining service life if under 8 years old. A 64-slice machine under OEM service contract is the sweet spot for most outpatient CT centers — and the configuration buyers are most comfortable with.

128-slice and 256-slice systems unlock specialty service lines: coronary CTA, CT angiography, advanced cardiac imaging. These machines cost $1.2-2.0M new and carry service contracts of $90-140K/year, but they can support a cardiac CT program that generates $400-800 per study instead of $150-250. If you're running a meaningful cardiac or CTA book on a 128+ slice machine, you can push your multiple toward 7.5-8x.

Specialty Service Lines That Move the Multiple

The single biggest differentiator between a 5.5x CT center and a 7.5x CT center is the service line mix. Generic outpatient CT — trauma, chest, abdomen — is a commodity, and you'll be priced like one. Specialty volume commands a premium.

Lung cancer screening is the easiest program to build and one of the most valuable. Medicare covers annual low-dose lung CT screening for eligible smokers, and volume has been growing 15-20% a year since USPSTF expanded the age criteria. A center with 8-15 screening studies a day has a genuinely differentiated asset, and cardiology or pulmonology-affiliated buyers will pay up.

Cardiac CT and coronary CTA is the highest-value service line you can run. It requires a 128+ slice system, cardiology reading credentials, and a referral base of cardiologists and primary care, but per-study economics are 2-4x a routine chest CT. Cardiology groups and heart hospitals will pay strategic premiums for centers with established cardiac CT programs.

Interventional prep and image-guided biopsies keep your scanner busy during lower-volume hours and carry good reimbursement. They also deepen referrer relationships in ways that commodity imaging doesn't.

The Contrast and Staffing Problem

CT has operational complications MRI doesn't. You need a physician or advanced practice clinician on-site or on-call for contrast reactions, and contrast media shortages (the 2022 Omnipaque crisis is still fresh in buyer memory) have made acquirers wary of centers without diversified contrast supply agreements.

Staffing is also tighter. You need CT-credentialed technologists, and in most metro markets that's become a wage pressure issue. A center with stable, credentialed tech staff and documented contrast protocols will trade meaningfully better than one where the owner-physician is the only person who really understands the workflow.

What Destroys CT Center Value

Obsolete equipment. A 16-slice or early 64-slice scanner past year 10 is functionally a liability. Buyers will price it at zero and deduct replacement cost.

Over-reliance on one or two referrers. CT referral patterns are stickier than MRI because of workflow integration, which means a dominant referrer is simultaneously a strength and a massive concentration risk. If one ortho group sends you 50% of your volume, expect buyers to price a contingency.

Uncollected A/R and denial rates. CT billing is more complex than MRI because of contrast, without/with combinations, and modifier-sensitive CPT coding. A center with 90+ day A/R over 25% of total A/R signals billing problems that will come out in quality of earnings diligence.

How to Maximize Your CT Center Exit

Build a screening or specialty program. Lung cancer screening is the lowest-hanging fruit. It takes 6-12 months to build meaningful volume, and it's worth 0.5-1.0x of EBITDA in the eventual multiple.

Upgrade if you're on a 16-slice. It feels expensive, but the math works. A used 64-slice replacement at $400-600K can add $1.0-1.5M to your enterprise value and make your center actually sellable to strategics.

Clean up referral concentration. Build relationships with at least 15-20 meaningful referring providers before going to market.

Know your number. Run an instant valuation before taking any buyer calls so you understand what your center should actually trade for.

The Bottom Line

CT centers trade in a similar 5-8x EBITDA band as MRI, but the path to the high end of that range is different. Where MRI is about scan volume and magnet quality, CT is about throughput, slice count, and whether you've built specialty service lines that pull you out of the commodity bucket. A well-positioned CT center with cardiac or screening volume and modern equipment can absolutely earn a 7.5-8x multiple — but it takes intentional preparation, not just good luck with inbound buyer calls.